Insider Trading April 21, 2026 04:16 PM

Arteris Director Executes $1.99M in Stock Sales Under 10b5-1 Plan

Transactions routed through a family trust reduce indirect holdings while company posts stronger-than-expected Q4 2025 results

By Maya Rios AIP
Arteris Director Executes $1.99M in Stock Sales Under 10b5-1 Plan
AIP

Saiyed Atiq Raza, a director of Arteris, Inc. (NASDAQ: AIP), sold roughly $1.99 million in company shares across two trades on April 17 and April 20, 2026, under a 10b5-1 plan adopted November 7, 2025. The sales were executed via a revocable trust for which Mr. Raza serves as trustee. The disclosure comes as the stock trades near its 52-week high and following a better-than-expected fourth-quarter 2025 report.

Key Points

  • Director Saiyed Atiq Raza sold approximately $1.99 million in Arteris stock in two transactions on April 17 and April 20, 2026, under a 10b5-1 plan.
  • Transactions were executed indirectly through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust; post-sale holdings include 300,000 shares indirectly and 20,839 shares directly.
  • Arteris shares are trading near a 52-week high with a 288% one-year return and a market capitalization of $1.03 billion; the company also reported Q4 2025 results that beat expectations.

Saiyed Atiq Raza, who serves on the board of Arteris, Inc. (NASDAQ: AIP), completed two insider stock sales last week totaling about $1.99 million. The disposals were carried out on April 17 and April 20, 2026, and were executed pursuant to a pre-established 10b5-1 trading plan that was adopted on November 7, 2025.

On April 17, Mr. Raza sold 72,940 shares of Arteris common stock at a weighted average price of $22.1589 per share. That day's activity consisted of multiple transactions, with execution prices spanning from $22.00 to $22.46. Three days later, on April 20, he sold an additional 17,060 shares at a weighted average price of $22.162 per share, with individual sale prices ranging between $22.05 and $22.24.

Both sets of trades were conducted indirectly through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which Mr. Raza is the trustee. After these transactions, Mr. Raza retains indirect ownership of 300,000 shares through the trust and directly holds 20,839 shares of Arteris common stock.


Context for the sales includes Arteris shares trading near their 52-week high of $22.80 and the stock having delivered a 288% return over the past year. The company’s market capitalization is reported at $1.03 billion.

On valuation, InvestingPro analysis included in the company disclosure indicates Arteris appears overvalued at current price levels based on its Fair Value assessment. The same note points investors to a comprehensive analysis and 13 additional ProTips available ahead of Arteris’ upcoming earnings report scheduled for April 30.


Separately, Arteris reported fourth-quarter 2025 results that exceeded market expectations. The company posted revenue of $20.1 million, above the projected $18.55 million, and delivered an earnings per share result of -$0.05, versus an anticipated -$0.07. Those outcomes were characterized as stronger-than-expected for the period.

The disclosure of Mr. Raza’s trades, the valuation commentary, and the recent quarterly results form the public record ahead of the company’s next scheduled reporting date. The transactions were executed under an established trading plan and routed through a revocable trust for which Mr. Raza is trustee, and the post-sale holdings reflect both direct and indirect ownership positions.

Risks

  • Insider selling - The director’s disposals, while executed under a prearranged 10b5-1 plan, reduce his indirect stake and may be interpreted as a factor by equity investors - impacts investor sentiment and equity markets.
  • Valuation concern - InvestingPro’s Fair Value assessment indicates Arteris appears overvalued at current levels, introducing valuation risk ahead of the next earnings report - impacts investors and market valuation metrics.
  • Earnings uncertainty - Although Q4 2025 results beat expectations, the company faces the usual uncertainty around upcoming financial results scheduled for April 30; future results could alter investor perceptions - impacts investors and short-term market reaction.

More from Insider Trading

SiTime Executive Disposes $1.17 Million in Shares Amid Elevated Stock Price Apr 21, 2026 Porch Group COO Sells $464,286 in Shares in Sell-to-Cover Transaction Apr 21, 2026 Porch Group CFO completes mandated sell-to-cover transaction totaling $65,866 Apr 21, 2026 SoftVest Increases Stake in Cross Timbers Royalty Trust with $343,161 Purchase Apr 21, 2026 FuelCell Energy Executive Sells $20,000 in Stock; Company Posts Q1 Shortfall Amid Product Push Apr 21, 2026